Polymorphisms in the interleukin 6 and transforming growth factor β1 gene and risk of dementia. The Rotterdam Study

Neuroscience Letters

Volumn 402, Issue 1-2, 2006, Pages 113-117

  van Oijen, Marieke ^a   Arp, Pascal P ^a   Jong, Frank Jan de ^a   Hofman, Albert ^a   Koudstaal, Peter J ^a   Uitterlinden, Andre G ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Dementia; Inflammation; Interleukin 6 (IL 6); Polymorphisms; Transforming growth factor 1 (TGF 1)

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DEMENTIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33747228489     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.03.050     Document Type: Article

References (37)

1. American Psychiatry Associtaion. Diagnostic and Statistical Manual of Mental Disorders, 1987.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
3. Araria-Goumidi L., Lambert J.C., Mann D.M., Lendon C., Frigard B., Iwatsubo T., Cottel D., Amouyel P., and Chartier-Harlin M.C. Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 73 (2002) 62-64
4. Arosio B., Trabattoni D., Galimberti L., Bucciarelli P., Fasano F., Calabresi C., Cazzullo C.L., Vergani C., Annoni G., and Clerici M. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol. Aging 25 (2004) 1009-1015
5. Barendregt J.J., and Ott A. Consistency of epidemiologic estimates. Eur. J. Epidemiol. 20 (2005) 827-832
6. Bhojak T.J., DeKosky S.T., Ganguli M., and Kamboh M.I. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci. Lett. 288 (2000) 21-24
7. Campbell I.L., Stalder A.K., Chiang C.S., Bellinger R., Heyser C.J., Steffensen S., Masliah E., Powell H.C., Gold L.H., Henriksen S.J., and Siggins G.R. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol. Psychiatry 2 (1997) 125-129
8. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Capurso A., and Panza F. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp. Gerontol. 39 (2004) 1567-1573
9. Chao C.C., Ala T.A., Hu S., Crossley K.B., Sherman R.E., Peterson P.K., and Frey II W.H. Serum cytokine levels in patients with Alzheimer's disease. Clin. Diagn. Lab. Immunol. 1 (1994) 433-436
10. Copeland J.R., Kelleher M.J., Kellett J.M., Gourlay A.J., Gurland B.J., Fleiss J.L., and Sharpe L. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability. Psychol. Med. 6 (1976) 439-449
11. Depboylu C., Lohmuller F., Gocke P., Du Y., Zimmer R., Gasser T., Klockgether T., and Dodel R.C. An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 17 (2004) 170-173
12. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., Stijnen T., Hofman A., Witteman J.C., and Breteler M.M. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol. 61 (2004) 668-672
13. Faltraco F., Burger K., Zill P., Teipel S.J., Moller H.J., Hampel H., Bondy B., and Ackenheil M. Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J. Am. Geriatr. Soc. 51 (2003) 578-579
14. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., and Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102 (1998) 1369-1376
15. Flanders K.C., Lippa C.F., Smith T.W., Pollen D.A., and Sporn M.B. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 45 (1995) 1561-1569
16. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
17. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., Carter N.D., and Spector T.D. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 8 (1999) 93-97
18. Hofman A., Grobbee D.E., de Jong P.T., and van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur. J. Epidemiol. 7 (1991) 403-422
19. Hull M., Berger M., Volk B., and Bauer J. Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques. Ann. N.Y. Acad. Sci. 777 (1996) 205-212
20. Licastro F., Grimaldi L.M., Bonafe M., Martina C., Olivieri F., Cavallone L., Giovanietti S., Masliah E., and Franceschi C. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol. Aging 24 (2003) 921-926
21. Luedecking E.K., DeKosky S.T., Mehdi H., Ganguli M., and Kamboh M.I. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum. Genet. 106 (2000) 565-569
22. Mattson M.P., Barger S.W., Furukawa K., Bruce A.J., Wyss-Coray T., Mark R.J., and Mucke L. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res. Brain Res. Rev. 23 (1997) 47-61
23. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
24. Nishimura M., Sakamoto T., Kaji R., and Kawakami H. Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci. Lett. 368 (2004) 140-143
25. Ott A., Breteler M.M., van Harskamp F., Stijnen T., and Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am. J. Epidemiol. 147 (1998) 574-580
26. Pola R., Flex A., Gaetani E., Lago A.D., Gerardino L., Pola P., and Bernabei R. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population (corrected). Neuroreport 13 (2002) 1645-1647
27. Prehn J.H., Backhauss C., and Krieglstein J. Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13 (1993) 521-525
28. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.-M., Brun A., Hofman A., Moody D.M., O'Brien M.D., Yamaguchi T., Grafman J., Drayer B.P., Bennett D.A., Fisher M., Ogata J., Kokmen E., Bermejo F., Wolf P.A., Gorelick P.B., Bick K.L., Pajeau A.K., Bell M.A., DeCarli C., Culebras A., Korczyn A.D., Bogousslavsky J., Hartmann A., and Scheinberg P. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (1993) 250-260
29. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., and Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 149 (1986) 698-709
30. Shibata N., Ohnuma T., Takahashi T., Baba H., Ishizuka T., Ohtsuka M., Ueki A., Nagao M., and Arai H. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am. J. Med. Genet. 114 (2002) 436-439
31. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
32. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275 (2000) 18138-18144
33. van der Wal E.A., Gomez-Pinilla F., and Cotman C.W. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4 (1993) 69-72
34. Weaver J.D., Huang M.H., Albert M., Harris T., Rowe J.W., and Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59 (2002) 371-378
35. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., and Mucke L. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature 389 (1997) 603-606
36. Yucesoy B., Peila R., White L.R., Wu K.M., Johnson V.J., Kashon M.L., Luster M.I., and Launer L.J. Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiol. Aging 27 (2006) 211-217
37. Zhang Y., Hayes A., Pritchard A., Thaker U., Haque M.S., Lemmon H., Harris J., Cumming A., Lambert J.C., Chartier-Harlin M.C., St Clair D., Iwatsubo T., Mann D.M., and Lendon C.L. Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease. Neurosci. Lett. 362 (2004) 99-102